Report Code: 11372 | Available Format: PDF
Glaucoma Surgery Devices Market Overview
The global glaucoma surgery devices market is expected to witness extensive growth in the coming years because of increasing prevalence of glaucoma and incidence of associated surgeries. The subsequent rise in glaucoma surgical procedures can be majorly attributed to increasing geriatric population across the world, which bears a higher risk of the disease due to the weak optic nerve as a result of aging. According to the National Eye Institute statistics (2010), glaucoma affects more than 2.7 million people aged 40 years and above, ever year, in the U.S.
Glaucoma has emerged as a major cause of blindness among people across the world. It is caused by increased intraocular pressure within the eye because of improper drainage of the eye fluid. This escalated eye pressure, in turn, damages the eyesight. There are various treatment options available for glaucoma, including eye drops, pills, laser surgery, conventional surgery, or a combination of these methods.
Glaucoma surgery devices include various laser- and non-laser-based implants and other devices used for reducing the intraocular pressure in the eye by draining extra accumulated eye fluid. The glaucoma devices market is bifurcated into open-angle glaucoma and closed-angle glaucoma, on the basis of treatment, of which the open-angle glaucoma treatment category is expected to account for the larger share in the glaucoma surgery devices industry during the period the forecast period (2018–2023).
On the basis of product, the glaucoma surgery devices market is classified as drainage systems, laser-based devices, and implants, of which drainage systems are projected to account for the largest share in the industry during the forecast period.
The glaucoma surgery devices find application in conventional glaucoma surgeries and minimally invasive glaucoma surgeries, of which the minimally invasive glaucoma surgeries category is expected to witness faster growth in demand during the forecast period.
Hospitals, private ophthalmic clinics and ASCs constitute the end user base for the glaucoma surgery devices industry. Hospitals are expected to be the fastest growing end user category in the industry during the forecast period.
Glaucoma Surgery Devices Market Dynamics
Growth Drivers and Restraints
Increasing preference for micro-invasive glaucoma surgeries (MIGSs), rising geriatric population, and increasing incidence of eye-related disorders are some of the factors supporting the growth of the glaucoma surgery devices market globally.
However, lack of skilled professionals with inadequate knowledge about the glaucoma surgery devices, high cost of glaucoma surgical procedures, and increase in associated complications post-surgery are the key factors that may impede the market growth.
Opportunity and Trends
Increasing innovations and developments in the form of various technologically advanced implants such as micro-stents offer significant opportunities for the market players. Technologically advanced treatment options, such as laser-based surgeries, are expected to witness a significant rise, owing to their advantages such as minimal trauma caused to the patient and quick healing time. Moreover, factor such as unmet treatment needs in developing countries is further expected to provide growth avenues to the players in the market.
Glaucoma Surgery Devices Market Insights by Geography
In 2016, North America accounted for the largest share of the global glaucoma surgery devices market, followed by the Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Growth in the top two regions, North America and the Europe, is mainly attributable to the increasing adoption of technologically advanced devices for glaucoma surgeries in these regions.
The Asia-Pacific, Latin American, and Middle Eastern and African market growth is primarily driven by increase in surgical procedures associated with open- and closed-angle glaucoma.
Glaucoma Surgery Devices Market Competitive Landscape
Increasing prevalence of glaucoma has inevitably increased the demand for glaucoma surgery devices among ophthalmologists across the world. With availability of several treatment options and increased focus on innovative approaches for treating glaucoma, key players of the industry are working toward introducing advanced products and technologies in the market.
In April 2017, Alcon launched CyPass Micro-Stent, designed for reducing intraocular pressure, in the European market. The product is commercially available in the U.K., Germany, Italy, and Spain. In November 2016, Allergan Plc. received approval from the U.S. Food and Drug Administration (FDA) for XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) for use in the U.S.
Some other key players in the glaucoma surgery devices market are Abbott Laboratories, Carl Zeiss Meditec AG, NIDEK Co. Ltd., Lumenis Ltd., and IRIDEX Corporation.
GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION
By End User
Get a bespoke market intelligence solution
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws